Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing pramipexole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pramipexole dihydrochloride 88 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pramipexole dihydrochloride 180 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pramipexole dihydrochloride 700 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pramipexole dihydrochloride 125micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pramipexole dihydrochloride 250micrograms tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pramipexole dihydrochloride 1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pramipexole dihydrochloride 1.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pramipexole dihydrochloride 500 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pramipexole dihydrochloride |
Is a |
False |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing pramipexole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramipexole dihydrochloride |
Is modification of (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only pramipexole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramipexole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramipexole (as pramipexole dihydrochloride) 520 microgram prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramipexole (as pramipexole dihydrochloride) 350 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 520 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.57 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pramipexole (as pramipexole dihydrochloride) 2.62 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pramipexole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |